# Kelly R. Bales

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/kelly-r-bales/

## Facts

| Field | Value |
| --- | --- |
| Citations | 22,325 |
| Field | Alzheimer's disease research and treatments |
| h-index | 71 |
| i10-index | 120 |
| Last Known Institution | Pfizer (United States) |
| OpenAlex ID | https://openalex.org/A5003879034 |
| Works | 197 |

## Researcher papers

- [Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease](https://scholariq.org/papers/minocycline-prevents-nigrostriatal-dopaminergic-neurodegeneration-in-the-mptp/)

## Researcher topics

- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)
- [Cholinesterase and Neurodegenerative Diseases](https://scholariq.org/topics/cholinesterase-and-neurodegenerative-diseases/)
- [Neuroscience and Neuropharmacology Research](https://scholariq.org/topics/neuroscience-and-neuropharmacology-research/)
- [Computational Drug Discovery Methods](https://scholariq.org/topics/computational-drug-discovery-methods/)
- [Neuroinflammation and Neurodegeneration Mechanisms](https://scholariq.org/topics/neuroinflammation-and-neurodegeneration-mechanisms/)

## Researcher university

- [Pfizer (United States)](https://scholariq.org/institutions/pfizer-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.